Torrent Pharma gets CDSCO panel nod to manufacture, market Pregabalin, Duloxetine FDC Medical Dialogues Team7 Nov 2021 11:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Submit interim safety report: CDSCO panel tells Novartis for phase 3 study of intrathecal OAV-101 Medical Dialogues Team7 Nov 2021 9:30 AM ISTNew Delhi: In a significant development, drug firm Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the...
Proud Moment for India: Bharat Biotech Covaxin gets WHO approval for emergency use listing Farhat Nasim6 Nov 2021 3:09 PM ISTBesides demonstrating 77.8 per cent effectiveness against symptomatic COVID, Covaxin has shown 65.2 per cent protection against the new Delta variant.
Pfizer secures CDSCO panel nod to study Hemophilia drug Marstacimab Medical Dialogues Team5 Nov 2021 6:13 PM ISTNew Delhi: In a significant development, drug firm Pfizer has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Bharat Biotech gets CDSCO nod for shelf-life extension of Covaxin Hina Zahid5 Nov 2021 3:39 PM ISTBengaluru: Bharat Biotech's COVID-19 vaccine has been granted an extension of shelf life for up to 12 months from the date of manufacture by India's...
Glenmark gets CDSCO panel nod to import, market Akynzeo Medical Dialogues Team4 Nov 2021 11:30 AM ISTNew Delhi: Granting a local clinical trial waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
CDSCO cautions employees against ransomware attack, sensitive data encryption Medical Dialogues Team3 Nov 2021 6:04 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has informed employees that the computer systems installed in CDSCO and the...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Roshni Dhar1 Nov 2021 11:24 AM ISTIn a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 29/October/2021 Roshni Dhar30 Oct 2021 11:09 AM ISTHere are Top Health Stories of the dayMadras HC slams Medical Council for removing gastroenterologist's name, gives 14 pointer guidelinesSlamming the...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Medical Dialogues Team27 Oct 2021 1:21 PM ISTNew Delhi: In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
CDSCO panel junks Novartis proposed clinical trial of oral treatment for C3 glomerulopathy Medical Dialogues Team25 Oct 2021 4:49 PM ISTNew Delhi: In a setback to pharma major Novartis, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization...
Novartis proposal to market Inclisiran with clinical trial waiver rejected by CDSCO panel Medical Dialogues Team24 Oct 2021 11:30 AM ISTNew Delhi: Rejecting Novartis Healthcare's proposal to import and market Inclisiran Solution for Injection with a local clinical trial waiver,...
